From: Clinical outcome measures in juvenile idiopathic arthritis
Physician global assessment | Parent/patient global assessment | Active joint count | Acute-phase reactant (range) | Score range (total) | |
---|---|---|---|---|---|
JADAS | |||||
• JADAS10 | 0–10-cm VAS | 0–10-cm VAS | Simple count, 0–10a | Normalized ESR (0–10)c | 0–40 |
• JADAS27 | 0–10-cm VAS | 0–10-cm VAS | Reduced count, 0–27 | Normalized ESR (0–10)c | 0–57 |
• JADAS71 | 0–10-cm VAS | 0–10-cm VAS | Simple count, 0–71 | Normalized ESR (0–10)c | 0–101 |
JADAS-CRP | |||||
• JADAS10-CRP | 0–10-cm VAS | 0–10-cm VAS | Simple count, 0–10a | Normalized CRP (0–10)b | 0–40 |
• JADAS27-CRP | 0–10-cm VAS | 0–10-cm VAS | Reduced count, 0–27 | Normalized CRP (0–10)b | 0–57 |
• JADAS71-CRP | 0–10-cm VAS | 0–10-cm VAS | Simple count, 0–71 | Normalized CRP (0–10)b | 0–101 |
cJADAS | |||||
• cJADAS-10 | 0–10-cm VAS | 0–10-cm VAS | Simple count, 0–10a | – | 0–30 |
• cJADAS-27 | 0–10-cm VAS | 0–10-cm VAS | Reduced count, 0–27 | – | 0–47 |
• cJADAS-71 | 0–10-cm VAS | 0–10-cm VAS | Simple count, 0–71 | – | 0–91 |